Refining Clinician- and Caregiver-Reported Outcome Measures for Evaluating Phelan-McDermid SyndromeLikeFollowShareShare your feedbackQuestions (0)Post questionYour question will be sent privately to Neuren Pharmaceuticals. The company may choose to make this question public.Start the conversationAsk Neuren Pharmaceuticals a question about this update.DiscoverShare your feedbackDiscover
